Inventor
BRAUN JONATHAN
US30 patents
⚠️ This page may combine multiple inventors who share the name “BRAUN JONATHAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV CALIFORNIA
22 patentsUS6309643B1Oct 30, 2001
IBD-associated microbial antigens and methods of using same
UNIV CALIFORNIA113 citations98
US6033864AMar 7, 2000
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
UNIV CALIFORNIA132 citations96
US5691151ANov 25, 1997
Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
UNIV CALIFORNIA76 citations96
US7138237B1Nov 21, 2006
Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
UNIV CALIFORNIA35 citations95
US5691135ANov 25, 1997
Immunoglobulin superantigen binding to gp 120 from HIV
UNIV CALIFORNIA22 citations86
US5738847AApr 14, 1998
Anti-VH3-15 reagents and methods for their use
UNIV CALIFORNIA11 citations74
US6759530B2Jul 6, 2004
IBD-associated microbial nucleic acid molecules
UNIV CALIFORNIA4 citations73
US6320037B2Nov 20, 2001
IBD-associated microbial nucleic acid molecules
UNIV CALIFORNIA5 citations73
US7183065B2Feb 27, 2007
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
UNIV CALIFORNIA9 citations71
US10413577B2Sep 17, 2019
Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
UNIV CALIFORNIA6 citations67
US10028983B2Jul 24, 2018
Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
UNIV CALIFORNIA4 citations67
US7557194B2Jul 7, 2009
Antibody materials for an IBD-associated polypeptide
UNIV CALIFORNIA2 citations62
US6537768B1Mar 25, 2003
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC panca antigens
UNIV CALIFORNIA4 citations60
US11053310B2Jul 6, 2021
Antibodies for the treatment of cancers
UNIV CALIFORNIA0 citations59
US6821739B2Nov 23, 2004
Methods of diagnosing and treating Crohn's disease using Pseudomonas antigens
UNIV CALIFORNIA5 citations57
US8951740B2Feb 10, 2015
Genotoxicity as a biomarker for inflammation
UNIV CALIFORNIA0 citations50
US8940491B2Jan 27, 2015
Genotoxicity as a biomarker for inflammation
UNIV CALIFORNIA0 citations50
US8785602B2Jul 22, 2014
EMP2 antibodies and methods of use thereof for causing regression of a solid tumor or symptoms thereof
UNIV CALIFORNIA0 citations48
US8779104B2Jul 15, 2014
EMP2 antibodies and methods of use thereof causing regression of a solid tumor or symptoms thereof
UNIV CALIFORNIA0 citations48
US9624304B2Apr 18, 2017
Antibodies which bind to epithelial membrane protein 2 (EMP2)
UNIV CALIFORNIA0 citations47
US9011857B2Apr 21, 2015
Methods of treating cancer by administering EMP2 antibodies
UNIV CALIFORNIA0 citations46
US10385395B2Aug 20, 2019
Diagnostic tools for response to 6-thiopurine therapy
UNIV CALIFORNIA0 citations42
BRAUN JONATHAN
3 patentsCEDARS SINAI MEDICAL CENTER
3 patentsUS7993867B2Aug 9, 2011
Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen
CEDARS SINAI MEDICAL CENTER4 citations72
US7993865B2Aug 9, 2011
Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
CEDARS SINAI MEDICAL CENTER4 citations72
US7993866B2Aug 9, 2011
Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen
CEDARS SINAI MEDICAL CENTER4 citations72